AlphaCrest Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,718
| Closed | -$738K | – | 776 |
|
|
2022
Q3 | $738K | Sell |
9,718
-16,762
| -63% | -$1.27M | 0.05% | 780 |
|
|
2022
Q2 | $1.84M | Buy |
26,480
+19,485
| +279% | +$1.35M | 0.09% | 364 |
|
|
2022
Q1 | $580K | Sell |
6,995
-18,907
| -73% | -$1.57M | 0.03% | 828 |
|
|
2021
Q4 | $1.95M | Buy |
25,902
+15,302
| +144% | +$1.15M | 0.07% | 447 |
|
|
2021
Q3 | $1.23M | Buy |
10,600
+7,288
| +220% | +$846K | 0.06% | 518 |
|
|
2021
Q2 | $735K | Sell |
3,312
-4,477
| -57% | -$994K | 0.03% | 799 |
|
|
2021
Q1 | $1.03M | Buy |
+7,789
| New | +$1.03M | 0.06% | 488 |
|
|
2020
Q4 | – | Sell |
-2,300
| Closed | -$256K | – | 1227 |
|
|
2020
Q3 | $256K | Sell |
2,300
-3,000
| -57% | -$334K | 0.03% | 946 |
|
|
2020
Q2 | $314K | Sell |
5,300
-5,000
| -49% | -$296K | 0.05% | 608 |
|
|
2020
Q1 | $694K | Buy |
10,300
+5,900
| +134% | +$398K | 0.08% | 426 |
|
|
2019
Q4 | $371K | Sell |
4,400
-12,900
| -75% | -$1.09M | 0.03% | 954 |
|
|
2019
Q3 | $1.29M | Buy |
17,300
+6,100
| +54% | +$456K | 0.08% | 426 |
|
|
2019
Q2 | $708K | Buy |
+11,200
| New | +$708K | 0.06% | 555 |
|